Ferric Citrate and Chronic Kidney Disease in Children

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.

Also called NCT04741646

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04741646
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04741646. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-17 (actual); primary completion 2027-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ferric Citrate and Chronic Kidney Disease in Children
Acronym
FIT4KID
Condition
Chronic Kidney Diseases
Intervention (Drug)
Ferric Citrate
Intervention (Drug)
Placebo
Lead sponsor
University of California, Los Angeles (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct04741646
Content hash
4f39b8e5b750bee11bc5c9b3a9fb6c97f87d5057602598a93ba1dec313830fc9